Conversely, inhibiting KAI1/CD82 palmitoylation by mutating the palmitoylation site dramatically impairs the formation and organization of N‐cadherin clusters, and subsequently diminishes bone marrow homing of AML [65] (Fig. 2, Table 1). Here, CD82 is linked to acute myeloid leukemia.